Both in Biotechnology
Tenaya Therapeutics vs enGene Therapeutics
Over the past year TNYA returned −62.5% and ENGN returned −69.8%; their daily moves had a correlation of 0.00.
TNYA −62.5% ENGN −69.8%Growth of $1, one year, split-adjusted
| Metric | TNYA | ENGN |
|---|---|---|
| Price | $0.5931 | $1.95 |
| Market cap | $133.0M | $130.7M |
| Today | +0.56% | −1.02% |
| 1 month | −14.1% | +6.8% |
| 6 months | −4.3% | −68.4% |
| Year to date | −16.6% | −78.4% |
| 1 year | −64.3% | −70.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −3909.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 99.6× | — |
| Net cash | $78.1M | $241.0M |
| Dividend yield | — | — |
| Volatility (60d) | 45.2% | 45.3% |
| Short % of float | 13.0% | 2.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).